Phase II Cardiac Rehabilitation
Links shared publicly online about this topic
Revista Brasileira de Fisioterapia - Heart rate responses during isometric exercises in patients undergoing a phase III cardiac rehabilitation program
scielo.br — “Revista Brasileira de Fisioterapia - Heart rate responses during isometric exercises in patients undergoing a phase III cardiac rehabilitation program” View full resource at scielo.br
Most Recently Shared on December 19, 2010 at 7:28 pm By:
Heart rate responses during isometric exercises in patients undergoing a phase III cardiac rehabilitation progra... http://bit.ly/gHDEDH
Launch Of First Phase II Trial Of Heart Disease Treatment For Duchenne Muscular Dystrophy
medicalnewstoday.com — “Kennedy Krieger Institute has announced the launch of a first-of-its-kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DM” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2010 at 1:05 pm By:
Launch Of First Phase II Trial Of Heart Disease Treatment For Duchenne Muscular Dystrophy http://mnt.to/3L9R #menshealth
First phase II trial of heart disease treatment for Duchenne muscular dystrophy launched
eurekalert.org — “Kennedy Krieger announced the launch of a first-of-its-kind phase II clinical trial to investigate a treatment for heart disease in Duchenne muscular dystrophy (DMD). Made possible by a $545,000 grant from Pilot Trials Now, a DMD initiative of Charley's Fund Inc. and the Nash Avery Foundation, with additional support from Pfizer Inc., the study will examine whether Revatio (sildenafil) improves cardiac function for those affected by the most common fatal genetic disorder in the world.” View full resource at eurekalert.org
Most Recently Shared on October 12, 2010 at 3:35 pm By:
First phase II trial of heart disease treatment for Duchenne muscular dystrophy launched: ( Kennedy Krieger Instit... http://bit.ly/aGMZHD
Sanofi Pasteur Starts A Phase II Vaccine Trial For Primary Prevention Of Clostridium Difficile
medicalnewstoday.com — “Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that it has started its phase II clinical study of a vaccine for primary prevention of Clostridium difficile infection (CDI” View full resource at medicalnewstoday.com
Most Recently Shared on November 30, 2010 at 3:06 pm By:
Sanofi Pasteur Starts A Phase II Vaccine Trial For Primary Prevention Of Clostridium Difficile http://mnt.to/3Nhh #vaccines #immunesystem
Pixantrone Associated With Up To 4-Fold Reduction In Severe (Grade 3-4) Cardiac Toxicity When Compared To Doxorubicin In CHOP-R Regimen
medicalnewstoday.com — “Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA) reported preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the st” View full resource at medicalnewstoday.com
Most Recently Shared on May 20, 2010 at 2:08 pm By:
MNT Pharma News Health News and Pharma
Pixantrone Associated With Up To 4-Fold Reduction In Severe (Grade 3-4) Cardiac Toxicity When Compared To Doxorubicin ... http://mnt.to/3CRb
Cardiology Terminology: Intrinsic Pacemaker (Part II: The AV Node and the Purkinge Fibers) - A Nurse's Thoughts on Natural Medicine | Dr. Sinatra
blog.drsinatra.com — “Jan Sinatra, APRN, is a cardiac rehabilitation nurse who, as the wife of Dr. Stephen Sinatra, shares his interest in integrative medicine.” View full resource at blog.drsinatra.com
Most Recently Shared on March 29, 2011 at 12:34 pm By:
Dr. Stephen Sinatra Nutritionist, Physician, Doctor, Internist, and Cardiologist
Cardiology Terminology: Intrinsic Pacemaker (Part II: The AV Node and the Purkinge Fibers): Today, I want to tel... http://bit.ly/gpUCSt
Adult stem cells may improve cardiac function in angina patients; Study finds improvement in chest pain and exercise tolerance
sciencedaily.com — “A new Phase II study found injections of adult patients' own stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina.” View full resource at sciencedaily.com
Most Recently Shared on July 8, 2011 at 12:08 pm By:
Adult stem cells may improve cardiac function in angina patients; Study finds improvement in chest pain and exer... http://bit.ly/rhG46L
Adult stem cells may improve cardiac function in angina patients; Study finds improvement in chest pain and exercise tolerance
sciencedaily.com — “A new Phase II study found injections of adult patients' own stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina.” View full resource at sciencedaily.com
Most Recently Shared on July 8, 2011 at 12:07 pm By:
ScienceDaily: Adult stem cells may improve cardiac function in angina patients; Study finds http://bit.ly/qgwGC2 Full http://bit.ly/qS1yGN
Mount Sinai gene therapy improves cardiac function in people with severe heart failure
news-medical.net — “Researchers at Mount Sinai School of Medicine have found in a Phase II trial that a gene therapy developed at Mount Sinai stabilized or improved cardiac function in people with severe heart failure. Patients receiving a high dose of the therapy, called SERCA2a, experienced substantial clinical benefit and significantly reduced cardiovascular hospitalizations, addressing a critical unmet need in this population.” View full resource at news-medical.net
Most Recently Shared on June 29, 2011 at 11:58 am By:
Mount Sinai gene therapy improves cardiac function in people with severe heart failure: Researchers at Mount Sin... http://bit.ly/mFPi4d
New Gene Therapy Proves Effective In Treating Severe Heart Failure
medicalnewstoday.com — “Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR®) is a gene therapy” View full resource at medicalnewstoday.com
Most Recently Shared on June 4, 2010 at 4:28 am By:
MNT Cardiovascular Health News
New Gene Therapy Proves Effective In Treating Severe Heart Failure http://mnt.to/3Dvm #cardiovascular
TCA Cellular Therapy Presents Adult Stem Cell Findings To European Society Of Cardiology Congress
medicalnewstoday.com — “This week tca cellular therapy`s medical director gabriel lasala, m.d. presents advance” View full resource at medicalnewstoday.com
Most Recently Shared on September 2, 2009 at 5:26 pm By:
MedicalNewsToday: TCA Cellular Therapy Presents Adult Stem Cell Findings To European Society: http://bit.ly/oKvru Full http://bit.ly/3US1Bw
Medical News: Stem Cells May Ease Angina in Tough Cases - in Cardiovascular, Acute Coronary Syndrome from MedPage Today
medpagetoday.com — “Cardiac injections of hematopoietic stem cells can help relieve refractory chest pain, a large phase II study determined.” View full resource at medpagetoday.com
Most Recently Shared on July 7, 2011 at 9:07 pm By:
Injecting stem cells into the heart may ease refractory chest pain: http://bit.ly/owXJBe
Medical News: Stem Cells May Ease Angina in Tough Cases - in Cardiovascular, Acute Coronary Syndrome from MedPage Today
medpagetoday.com — “Cardiac injections of hematopoietic stem cells can help relieve refractory chest pain, a large phase II study determined.” View full resource at medpagetoday.com
Most Recently Shared on July 7, 2011 at 9:33 pm By:
Stem Cells May Ease Angina in Tough Cases (CME/CE, with audio) http://bit.ly/oGrCWX
Mount Sinai Researchers Develop New Gene Therapy for Heart Failure - Drugs.com MedNews
drugs.com — “Researchers at Mount Sinai School of Medicine have found in a Phase II trial that a gene therapy developed at Mount Sinai stabilized or improved cardiac functio” View full resource at drugs.com
Most Recently Shared on June 29, 2011 at 5:14 pm By:
Drugs and Devices OW OW Health
Mount Sinai Researchers Develop New Gene Therapy for Heart Failure: Researchers at Mount Sinai School of M... http://bit.ly/lfoHXp #drug
Medical News: Novel Heart Failure Drug Effective in Small Studies - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “An experimental myosin activator drug improved cardiac function in patients with chronic stable systolic heart failure, according to a phase II study.” View full resource at medpagetoday.com
Most Recently Shared on August 24, 2011 at 1:23 pm By:
Dr E Michael Weiss - HeartAndSoulDoc Doctor, Internist, Cardiologist, and Physician
Medical News: Novel Heart Failure Drug Effective in Small Studies - in Cardiovascular, CHF from MedPage Today http://t.co/RYN46MN
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Heart Disease OW
Organizing heart disease resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Men's Health
The latest men's health news published daily. Articles from research centers, universities and prestigious journals.
-
Heart Disease OW
Organizing heart disease resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
